Lapatinib and Letrozole as First-Line Therapy for Metastatic Breast Cancer: Case Report of Bone Metastasis 18 Years Later. Issue 6 (November 2013)

• Record Type: Journal Article
• Authors: Mariani, Gabriella; Ricchini, Francesca; Sica, Lorenzo; Bianchi, Giulia Valeria
• Is Part Of: Tumori. Volume 99:Issue 6(2013)
• Page Start: e264
• Page End: e268
• Publication Date: 2013-11
• Subjects: breast cancer -- lapatinib -- letrozole -- metastases; Cancer -- Periodicals; 616.994
• DOI: 10.1177/030089161309900616
• Languages: English
• ISSNs: 0300-8916

Abstract

We describe a 63-year-old woman with a diagnosis of breast cancer who relapsed with multiple bone lesions 18 years later. The biological characteristics were estrogen receptor positive, progesterone receptor positive, and HER2-positive cancer. Lapatinib and letrozole was the treatment of choice as a manageable and active first-line therapy for this patient.